院内心脏骤停前预测生存:诊断准确性研究的系统评价
该系统评价检索Medline、Embase和Cochrane Library至2022年1月,纳入23项历史队列/病例对照研究(仅成人),评估13种骤停前临床决策工具对院内心脏骤停生存结局的预测准确性。12项研究评估8种评分预测生存结局,11项研究使用5种评分预测神经结局。各评分准确性差异很大,预测出院存活/30天存活的阴性预测值从55.6%到100%不等;GO-FAR评分在7项研究中预测CPC 1存活的NPV为95.0%至99.2%。所有预测评分的证据确定性均评为极低。结论认为无评分足够可靠以支持临床实践,且未发现儿童证据。
要点
- 共纳入23项研究、13种骤停前评分,全部为历史队列/病例对照设计,仅成人,证据确定性均为极低。
- 12项研究评估8种评分预测出院存活/30天存活,阴性预测值范围55.6%至100%,各评分准确性差异大。
- GO-FAR评分在7项研究中预测CPC 1存活的阴性预测值为95.0%至99.2%。
- 两种评分评估CPC≤2存活,但均未获外部验证。
- 系统评价结论:无评分足够可靠支持临床实践,且未发现儿童证据。
适用人群与场景
- 纳入研究的受试者均为成人,无儿童证据。
- 研究场景为院内心脏骤停(IHCA)前的临床决策工具评估。
研究设计与关键结果
- 系统评价纳入23项研究,使用13种不同评分:12项研究调查8种评分评估生存结局,11项研究使用5种评分预测神经结局。
- 所有研究均为历史队列/病例对照设计,仅纳入成人。
- 每个评分的测试准确性差异很大;在12项评估出院存活/30天存活的评分研究中,预测存活的阴性预测值从55.6%到100%不等。
- GO-FAR评分在7项研究中评估,预测脑功能分级(CPC)1存活的阴性预测值范围为95.0%至99.2%。
- 两种评分评估CPC≤2存活,且未进行外部验证。
- 所有预测评分的证据确定性均评为极低。
证据类型、等级与局限
- 证据类型:系统评价(诊断准确性研究),检索Medline、Embase和Cochrane Library自建库至2022年1月,纳入随机和非随机研究,使用QUADAS框架评估偏倚风险,GRADE方法评估证据确定性。
- 所有预测评分的证据确定性均评为极低。
- 局限:无评分足够可靠以支持临床实践;未发现儿童证据。
对床旁实践的改变
- 系统评价结论认为,无评分足够可靠以支持其在临床实践中使用。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
AIM: To evaluate the test accuracy of pre-arrest clinical decision tools for in-hospital cardiac arrest survival outcomes.
METHODS: We searched Medline, Embase, and Cochrane Library from inception through January 2022 for randomized and non-randomized studies. We used the Quality Assessment of Diagnostic Accuracy Studies framework to evaluate risk of bias, and Grading of Recommendations Assessment, Development and Evaluation methodology to evaluate certainty of evidence. We report sensitivity, specificity, positive predictive outcome, and negative predictive outcome for prediction of survival outcomes. PROSPERO CRD42021268005.
RESULTS: We searched 2517 studies and included 23 studies using 13 different scores: 12 studies investigating 8 different scores assessing survival outcomes and 11 studies using 5 different scores to predict neurological outcomes. All were historical cohorts/ case control designs including adults only. Test accuracy for each score varied greatly. Across the 12 studies investigating 8 different scores assessing survival to hospital discharge/ 30-day survival, the negative predictive values (NPVs) for the prediction of survival varied from 55.6% to 100%. The GO-FAR score was evaluated in 7 studies with NPVs for survival with cerebral performance category (CPC) 1 ranging from 95.0% to 99.2%. Two scores assessed survival with CPC ≤ 2 and these were not externally validated. Across all prediction scores, certainty of evidence was rated as very low.
CONCLUSIONS: We identified very low certainty evidence across 23 studies for 13 different pre-arrest prediction scores to outcome following IHCA. No score was sufficiently reliable to support its use in clinical practice. We identified no evidence for children.
参考来源
- Lauridsen KG, Djärv T, Breckwoldt J, et al. Pre-arrest prediction of survival following in-hospital cardiac arrest: A systematic review of diagnostic test accuracy studies. Resuscitation. 2022. PMID: 35933060. doi:10.1016/j.resuscitation.2022.07.041
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。